Showing 1 to 2 of 2 results


FDA Issues Black Box Warning for Veozah Due to Liver Damage Risk
The FDA issued a black box warning for the drug Veozah, used to treat hot flashes, due to rare but serious liver damage, mandating frequent blood tests and immediate reporting of symptoms.
FDA Issues Black Box Warning for Veozah Due to Liver Damage Risk
The FDA issued a black box warning for the drug Veozah, used to treat hot flashes, due to rare but serious liver damage, mandating frequent blood tests and immediate reporting of symptoms.
Progress
32% Bias Score

FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.

FDA Issues Black Box Warning for Menopausal Hot Flash Drug Veozah
The FDA issued a black-box warning for Veozah, a non-hormonal drug treating menopausal hot flashes, due to rare but serious liver injury risk, mandating increased blood tests and immediate treatment cessation upon symptom onset; nearly 29,000 patients used it in May 2024.
Progress
32% Bias Score
Showing 1 to 2 of 2 results